HELP · Helus Pharma Inc.
AI read · Good for HELP
The AI's read
The size of the improvement and better patient response and remission rates point to a possible new option for people whose current medicines have not worked. Most side effects were short-lived. Investigators still recorded 3 serious events tied to treatment, and another Phase 3 study is underway.